IC
IDXX icon

IKOS CIF’s Idexx Laboratories IDXX Stock Holding History

IKOS CIF’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-98
Closed -$8K – 263
2015
Q1 		$8K Sell
98
-2,998
-97% -$233K 0.02% 218
2014
Q4 		$227K Buy
+3,096
New +$217K 0.38% 133
2014
Q2 		– Sell
-854
Closed -$53K – 240
2014
Q1 		$53K Buy
+854
New +$50.9K 0.08% 179

Other funds holding IDXX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IKOS CIF's IDXX Position: Q2 2015 in Review

IKOS CIF sold out of Idexx Laboratories (IDXX) in Q2 2015, closing a stake of 98 shares — an estimated $8K sold.

IKOS CIF first reported a position in IDXX in Q1 2014 and held it in 3 quarters. The position peaked at $227K in Q4 2014. 348 funds tracked by Wall St. Rank hold IDXX as of Q2 2015.

  • IKOS CIF reported no remaining Idexx Laboratories position as of Q2 2015 after selling out during the quarter.
  • IKOS CIF sold 98 Idexx Laboratories shares in Q2 2015, an estimated $8K.
  • IKOS CIF first reported a position in Idexx Laboratories in Q1 2014 and held it in 3 quarters.
  • IKOS CIF's Idexx Laboratories position peaked at $227K in Q4 2014.
  • 348 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2015.

Based on IKOS CIF's 13F filing for Q2 2015, filed 23 Jul 2015.